by Terry Chrisomalis Valeant Pharmaceuticals Intl Inc On November 18, 2015, Valeant Pharmaceuticals Intl Inc (NYSE:VRX) had received approval for two new indications of …
J.P.
PayPal Holdings Inc (NASDAQ:PYPL) rose 1% this morning after the company reported research about Chinese online shoppers. The report indicated that 35% of …
As always, it’s been a busy week in the biotechnology sector. Analysts remain bullish on both bluebird bio Inc (NASDAQ:BLUE) on the back …
Clovis Oncology Inc (NASDAQ:CLVS) announced that during its regularly scheduled Mid-Cycle Communication Meeting held last week with the U.S.
Clovis Oncology Inc (NASDAQ:CLVS) reported financial results for its quarter ended September 30, 2015, and provided an update on the Company’s clinical development …
Clovis Oncology Inc (NASDAQ:CLVS) announced that they have entered into a clinical trial collaboration with Genentech, a member of the Roche Group to evaluate …
Clovis Oncology Inc (NASDAQ:CLVS) announced that it has submitted its New Drug Application (NDA) regulatory filing to the U.S.
Clovis Oncology Inc (NASDAQ:CLVS) management did a great job setting realistic expectations during 1Q15 conference call on both regulatory timelines, and data releases …
Following the annual J.P.
